{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-016518","form_type":"8-K/A","ticker":"OLMA","cik":"0001750284","company_name":"Olema Pharmaceuticals, Inc.","filed_at":"2023-10-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.307095+00:00","generated_at":"2026-06-09T21:54:17.539586+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Olema appoints Scott Garland to board of directors with extensive launch experience","bullets":["Scott Garland appointed to Olema's Board as Class III director effective Oct 16, 2023.","Garland brings >30 years biopharma experience; former CEO of PACT Pharma and Portola.","He received initial equity grants: 21,520 shares (option) vesting over 3 years, and 14,347 shares (option) vesting by 2024 annual meeting.","Also receives annual cash retainer of $40,000 and additional $6,000 for Compensation Committee service.","Board cites his commercial expertise as crucial as palazestrant enters Phase 3."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-016518","json":"https://secwatch.observer/filing/0001558370-23-016518.json","markdown":"https://secwatch.observer/filing/0001558370-23-016518.md","text":"https://secwatch.observer/filing/0001558370-23-016518.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1750284/000155837023016518/0001558370-23-016518-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1750284/000155837023016518/olma-20231013x8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T21:54:17.539586+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"914be2fd16","claim":"Scott Garland was appointed as Class III Director at Olema Pharmaceuticals, Inc..","evidence_excerpt":"appointed Scott Garland to the Board as a Class III director, effective October 16, 2023","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1750284/000155837023016518/0001558370-23-016518-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class III Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}